Pulmonary Compliance
Pulmonary compliance describes the ease with which the lungs expand during inspiration. It reflects the combined elasticity of the lung tissue and the surface tension within the alveoli. High compliance means the lungs expand easily with minimal effort, whereas low compliance indicates the lungs are stiff and difficult to inflate. Compliance is a key determinant of the work of breathing, and its alteration underlies many respiratory conditions encountered in clinical practice.
What You Need to Know
Pulmonary compliance refers to how easily the lungs expand in response to pressure. High compliance means the lungs inflate easily, while low compliance means greater pressure is required to achieve the same volume change. Normal lung compliance depends on two key structural features: the elastic properties of lung tissue and the presence of surfactant within the alveoli. Elastic fibres within the lung parenchyma allow the lungs to stretch during inspiration and recoil during expiration, creating the driving force for passive exhalation. Without this recoil, air would not be expelled efficiently and ventilation would become energetically costly.
Surfactant, produced by type II alveolar cells, plays a critical role in reducing surface tension at the air–liquid interface inside the alveoli. By lowering surface tension, surfactant prevents small alveoli from collapsing and reduces the work required to reopen them with each breath. This allows the lungs to inflate smoothly and evenly, maintaining stable ventilation across millions of tiny air sacs. In its absence, such as in premature infants or severe lung injury, alveoli collapse more easily, dramatically lowering compliance and increasing the work of breathing.
Pulmonary compliance is therefore determined by the balance between tissue elasticity and surface tension forces, and disruption of either component alters breathing mechanics:
Healthy elastic fibres allow the lungs to stretch and recoil efficiently
Surfactant keeps alveoli open and reduces the pressure needed for inflation
The pleural system ensures that lung expansion follows chest wall movement
When compliance decreases, as in pulmonary fibrosis, acute respiratory distress syndrome, or pulmonary oedema, the lungs become stiff and resist inflation. Patients must generate much higher inspiratory pressures to achieve adequate tidal volumes, leading to rapid, shallow breathing and increased respiratory muscle fatigue. In contrast, when compliance is abnormally high, as in emphysema, the lungs inflate easily but lack sufficient elastic recoil to drive air out. This causes air trapping, hyperinflation, and difficulty with expiration, even though inspiration may seem effortless.
Beyond the Basics
Low Compliance and Restrictive Lung Disease
Low lung compliance is a defining mechanical feature of restrictive lung diseases, including pulmonary fibrosis, acute respiratory distress syndrome (ARDS), and severe pneumonia. In these conditions, lung tissue becomes thickened, inflamed, or fluid-filled, reducing its ability to stretch in response to normal pressure changes. As a result, greater inspiratory effort is required to generate even small increases in lung volume.
Patients typically compensate by adopting a pattern of rapid, shallow breathing. This strategy minimises the energy required to inflate stiff lungs but comes at the cost of reduced tidal volume and diminished alveolar ventilation. Although respiratory rate increases, effective gas exchange often worsens because a greater proportion of each breath is wasted ventilating anatomical dead space.
In severe ARDS, lung compliance may be so profoundly reduced that even high levels of positive pressure are required to achieve minimal lung expansion. This creates a narrow therapeutic window, as excessive pressures risk ventilator-induced lung injury, while insufficient pressures result in alveolar collapse and refractory hypoxaemia.
High Compliance and Loss of Elastic Recoil
In contrast, high lung compliance is characteristic of obstructive lung diseases such as emphysema. In this setting, destruction of alveolar walls and elastic fibres increases the ease with which the lungs expand. However, this apparent advantage is offset by a critical loss of elastic recoil.
Patients with emphysema can inhale relatively easily, but passive expiration becomes ineffective. Airways collapse prematurely during exhalation, trapping air within the lungs and leading to progressive hyperinflation. As lung volumes increase, the diaphragm flattens and loses mechanical efficiency, further increasing the work of breathing.
Over time, expiration becomes an active process requiring recruitment of accessory muscles, particularly during exertion. This increased muscular demand contributes to fatigue, exercise intolerance, and the sensation of breathlessness despite preserved inspiratory capacity.
Chest Wall Compliance and Ventilatory Mechanics
Overall respiratory compliance reflects not only the properties of the lungs but also the compliance of the chest wall. The rib cage, diaphragm, and respiratory muscles must all move freely to allow effective ventilation. Conditions such as kyphosis, obesity, ascites, or neuromuscular disease reduce chest wall compliance, increasing the pressure required to expand the thoracic cavity.
In these situations, lung tissue itself may be normal, yet ventilation remains mechanically difficult. Reduced chest wall compliance increases the work of breathing and can exacerbate respiratory failure, particularly during illness or fatigue.
When mechanical ventilation is required, clinicians must consider both lung and chest wall compliance. High airway pressures may reflect stiff lungs, a stiff chest wall, or a combination of both, and inappropriate ventilator settings can lead to underinflation, barotrauma, or haemodynamic compromise.
Surfactant and Dynamic Compliance
Pulmonary surfactant plays a crucial role in maintaining normal compliance by reducing alveolar surface tension. When surfactant levels are reduced or surfactant function is impaired, alveoli collapse more readily at end-expiration, and substantially higher pressures are required to reopen them during inspiration.
This loss of surfactant dramatically increases the work of breathing and reduces dynamic compliance, particularly at low lung volumes. In premature infants, immature Type II pneumocytes produce insufficient surfactant, resulting in widespread alveolar collapse and neonatal respiratory distress syndrome.
In adults with ARDS, surfactant dysfunction contributes to heterogeneous lung collapse and poor compliance. Clinical strategies such as positive end-expiratory pressure (PEEP) aim to maintain alveolar recruitment and prevent repeated collapse, thereby improving compliance and reducing ventilatory workload. In neonates, exogenous surfactant replacement directly restores surface tension regulation and improves lung mechanics.
Integration of Compliance in Respiratory Mechanics
Lung compliance, chest wall compliance, elastic recoil, and surfactant function together determine the mechanical efficiency of ventilation. Alterations in any one component shift the balance between pressure generation and volume change, increasing the work of breathing and predisposing to respiratory failure.
Clinical Connections
Pulmonary compliance describes how easily the lungs expand and has direct implications for work of breathing, gas exchange, and clinical management. Patients with low compliance present with rapid, shallow breathing, increased work of breathing, and impaired oxygenation. Pulmonary fibrosis causes a gradual stiffening of lung tissue, whereas acute conditions such as ARDS and pulmonary oedema can cause a sudden reduction in compliance, often leading to acute respiratory failure. These patients typically require higher pressures to achieve adequate ventilation, increasing the risk of barotrauma.
Key clinical patterns to recognise include:
Low compliance (e.g. ARDS, pulmonary oedema, fibrosis): reduced lung expansion, high inspiratory pressures required, rapid shallow breathing, decreased tidal volumes, and significant V/Q mismatch leading to hypoxaemia
High compliance (e.g. emphysema): lungs inflate easily but have poor elastic recoil, resulting in air trapping, hyperinflation, prolonged expiration, and incomplete lung emptying
Acute reduction in compliance: sudden deterioration in oxygenation, increased work of breathing, rapid escalation in respiratory support requirements
Chronic changes in compliance: gradual physiological adaptation with compensatory breathing patterns and increased reliance on accessory muscles
Patients with high compliance, particularly in emphysema, often develop barrel-shaped chests and chronic hyperinflation. Although inspiration may appear relatively easy, expiration becomes inefficient due to loss of elastic recoil. Many adopt pursed-lip breathing to maintain airway pressure during exhalation and reduce airway collapse, but the overall energy cost of breathing increases over time due to persistent air trapping.
Compliance plays a central role in clinical decision-making. It helps guide oxygen therapy, supports recognition of deteriorating respiratory patterns, and informs the need for ventilatory support. In mechanical ventilation, low-compliance lungs require careful pressure control to avoid further injury, while high-compliance lungs benefit from strategies that optimise expiratory flow and minimise dynamic hyperinflation.
Concept Check
Why do patients with low compliance breathe rapidly and shallowly?
What causes high compliance in emphysema, and why does it impair exhalation?
How does surfactant influence compliance?
Why does ARDS dramatically increase the work of breathing?
How does altered compliance affect mechanical ventilation?